1. Home
  2. EDUC vs OSRH Comparison

EDUC vs OSRH Comparison

Compare EDUC & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Educational Development Corporation

EDUC

Educational Development Corporation

HOLD

Current Price

$1.42

Market Cap

10.7M

ML Signal

HOLD

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.48

Market Cap

11.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDUC
OSRH
Founded
1965
N/A
Country
United States
United States
Employees
N/A
21
Industry
Consumer Specialties
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
11.7M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
EDUC
OSRH
Price
$1.42
$0.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.3K
781.5K
Earning Date
05-19-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.63
N/A
Revenue
$34,191,000.00
N/A
Revenue This Year
N/A
$9.30
Revenue Next Year
N/A
N/A
P/E Ratio
$2.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$0.38
52 Week High
$1.84
$1.79

Technical Indicators

Market Signals
Indicator
EDUC
OSRH
Relative Strength Index (RSI) 66.22 42.09
Support Level $1.25 $0.44
Resistance Level $1.42 $0.63
Average True Range (ATR) 0.06 0.09
MACD 0.01 0.00
Stochastic Oscillator 64.71 11.96

Price Performance

Historical Comparison
EDUC
OSRH

About EDUC Educational Development Corporation

Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: